Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer

Vandetanib (ZD6474) is an orally bioavailable small molecule tyrosine kinase inhibitor of multiple growth factor receptors, including RET (Rearrange during transfection), vascular endothelial growth factor receptor-2 (VEGFR-2) and epidermal growth factor receptor (EGFR). The activity against RET and...

Descripción completa

Detalles Bibliográficos
Autores principales: Deshpande, Hari, Roman, Sanziana, Thumar, Jaykumar, Sosa, Julie Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153121/
https://www.ncbi.nlm.nih.gov/pubmed/21836817
http://dx.doi.org/10.4137/CMO.S6197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153121/
https://www.ncbi.nlm.nih.gov/pubmed/21836817
http://dx.doi.org/10.4137/CMO.S6197

Ejemplares similares